|
| ||
| should I start meds & will this regimen work? Jun 1, 2006 I have been HIV positive since Oct. 2000. I have never been on meds. My latest Lab work came back of a Cd4 count of 378 and Viral Load of 12629. Over the years I have gone up and down on both counts, however, my last 3 tests have had my cd4s go down about 100. My Dr. thinks its time to start meds. What do you think? The regimen he wants to start me on is 4 Invirase with 1 Norvir and 1 Epzicom per day. Any help with this would be great. Thank you, Bernard |
||||||||||
|
|
Response from Dr. Wohl
Dear Bernard, You are getting close. There is no emergency to starting meds now but your counts sound like they are dropping steadily. So, it may be just a matter of time before you drop further - prompting a greater sense of urgency. When you do start HIV meds I would think twice about the regimen recommended to you. It is not a regimen that is a) considered a preferred regimen in any guidelines, b) not all that easy to take given the pill count, c) carries a 5-10% risk of an abacavir hypersensitivity reaction (less if you are of African descent) and d) may be very unlikely to be what your doctor would take were he to be HIV+. Why not something simpler and easier? Tenofovir+FTC+efavirenz is a potent regimen that is well tolerated and now comes as two pills before bed. Soon these will be in one single tablet. DW | |||||||||
Get Email Notifications When This Forum Updates or Subscribe With RSS
|
||||||||||
Q&A TERMS OF USE
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.
Review our complete terms of use and copyright notice.










